skip to main contentskip to main menuskip to footer Universität Bielefeld Play Search
  • Team

    © Universität Bielefeld

Alvaro Javier Feliz Morel

Exiris SRL, Italy - ESR 04
E-Mail: alvaro_felizmorel@exiris.it

Personal Information

Name Álvaro Javier Feliz Morel
Date of Birth 28/04/1994
Nationality Dominican Republic

Scientific Education

since 06/2020

Early Stage Researcher in the ETN Magicbullet::Reloaded at Exiris/Italy

PhD topic: Small molecule-drug conjugates containing HDAC inhibitors or tubulin-binding agents to enhance anti-tumor immune response. Exiris. Dr. Christian Steinküler, Dr. Gessica Filocamo and Norbert Sewald.

09/2018 – 07/2019

M.Sc. in Living Sciences (Genetics and Development) 2nd year at the University of Côte d’Azur/France.

Master thesis: Role of PTCH1 in chemotherapy resistance. IPMC (Institute of Molecular and Cellular Pharmacology/ Institute de Pharmacologie Moléculaire et Cellulaire). Dr. Isabelle Mus-Veteau.
09/2013 – 07/2018

B.Sc. in Biology at the Compluense University of Madrid/Germany.

Bachelor thesis: Effect of Kanamycin and dexamethasone in Rattus Norvegicus – Faculty of Biology UCM - Prof. Dr. Alberto Guillén Maestro

09/2016 – 07/2017

ERASMUS+. M.Sc. in Living Sciences (Genetics and Development) 1st year at the University of Côte d’Azur/France.

Master thesis: The role of VEGF-C in medulloblastoma resistance to chemo and radiotherapy. IRCAN (Institute of Research on Cancer and Aging, Nice). Dr. Sonia Martial.

Publications

  1. Penco-Campillo, M., Comoglio, Y., Feliz Morel, Á.J. et al. Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells. Commun Biol 3, 758 (2020). https://doi.org/10.1038/s42003-020-01502-2. [Link]

Presentations

  1. Poster participation: “Unexpected Effects of Photontherapy and Protontherapy on VEGFC Production and Tumor Aggressiveness in Different Medulloblastoma Subgroups”. 3rd ESM-EVBO Conference, MAASTRICHT, Netherlands. 2019.04

  2. Poster participation: “Unexpected Effects of Photontherapy on VEGFC Production and Tumor Aggressiveness in Two Medulloblastoma Subgroups” 8th Congress of French Angiogenesis Society. Reims, France. 2018.10

  3. Poster presentation “Immunotherapy: checkpoints blockade and side effects” at the XIII Congress for undergraduate students in living sciences. Madrid (Spain), Complutense University of Madrid. 2018.04.19 to 2018.04.21

     


back to top